The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary The National Institute of Allergy and Infectious Diseases (NIAID) a subsidiary of National Institutes of Health is a research institute that provides technological and therapeutic solutions. The institute develops therapies, diagnostic tests, vaccines, and other technologies to understand, immunologic, treat and prevent infectious, and allergic diseases. Its services include grants and funding, research and training, and health information. NIAID offers products for the treatment of bioterrorism, whooping cough, hepatitis A and B, rabies, meningitis, chickenpox, pneumococcal pneumonia, HIV/AIDS, malaria, tuberculosis and asthma. The institute conducts and supports research on infectious agents such as viruses, parasites, bacteria, fungi and prions. NIAID is headquartered in Bethesda, Maryland, the US. The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. 3
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH142862D Number of Pages : 29 Report Format : PDF Publisher Information : 4
5
Table Of Contents for The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8The National Institute of Allergy and Infectious Diseases, Medical Devices Deals, 2010 to YTD 2016 9The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deal Details 12Partnerships 12GlaxoSmithKline Enters into Research Agreement with NIAID 12PepTcell Enters into Research and Development Agreement National Institute of Allergy and Infectious Diseases 13SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases 14Zydus Cadila Healthcare Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 15GenVec Enters into Research Agreement with LMIV 16GeoVax Labs Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 17BioAegis Therapeutics Enters into Research Agreement with the National Institute of Allergy and Infectious Disease 18Emergent BioSolutions Signs Agreement with Oxford University, GlaxoSmithKline and NIAID for the Production of an MVA Ebola Zaire Vaccine Candidate 19DFH Pharma Enters Into Co-Development Agreement With NIAID For HIV Maturation Inhibitor Drugs 21ImmunoVaccine Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 22Licensing Agreements 23Butantan Institute Enters into Licensing Agreement with National Institute of Allergy and Infectious Diseases 23Exxell BIO Enters into Licensing Agreement with National Institute of Allergy and Infectious Diseases 24Polyplus-transfection Enters into Licensing Agreeement with NIAID and NCI 25The National Institute of Allergy and Infectious Diseases - Key Competitors 26Key Employees 27Locations And Subsidiaries 28Head Office 28Appendix 29Methodology 29About GlobalData 29Contact Us 29Disclaimer 29 6
List Of Tables in The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Key Facts 1 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 The National Institute of Allergy and Infectious Diseases, Deals By Therapy Area, 2010 to YTD 2016 8 The National Institute of Allergy and Infectious Diseases, Medical Devices Deals, 2010 to YTD 2016 9 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 GlaxoSmithKline Enters into Research Agreement with NIAID 12 PepTcell Enters into Research and Development Agreement National Institute of Allergy and Infectious Diseases 13 SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases 14 Zydus Cadila Healthcare Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 15 GenVec Enters into Research Agreement with LMIV 16 GeoVax Labs Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 17 BioAegis Therapeutics Enters into Research Agreement with the National Institute of Allergy and Infectious Disease 18 Emergent BioSolutions Signs Agreement with Oxford University, GlaxoSmithKline and NIAID for the Production of an MVA Ebola Zaire Vaccine Candidate 19 DFH Pharma Enters Into Co-Development Agreement With NIAID For HIV Maturation Inhibitor Drugs 21 ImmunoVaccine Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 22 Butantan Institute Enters into Licensing Agreement with National Institute of Allergy and Infectious Diseases 23 Exxell BIO Enters into Licensing Agreement with National Institute of Allergy and Infectious Diseases 24 Polyplus-transfection Enters into Licensing Agreeement with NIAID and NCI 25 The National Institute of Allergy and Infectious Diseases, Key Competitors 26 The National Institute of Allergy and Infectious Diseases, Key Employees 27 7
List Of Figures, Charts and Diagrams in The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 The National Institute of Allergy and Infectious Diseases, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 The National Institute of Allergy and Infectious Diseases, Medical Devices Deals, 2010 to YTD 2016 9 8
How to Buy... The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9